chrisvoncsefalvay/vaers-outcomes huggingface dataset:
L arm tingling; malaise; shortness of breath; tired/fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A 66-years-old female patient the first dose of received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced tired/fatigue on 05Mar2021, l arm tingling, malaise and shortness of breath on an unspecified date. During her 15-minute waiting period after the injection, the patient began to experience L arm tingling. Patient complains of malaise/fatigue (feels tired today.) And shortness of breath (chronic, not with exertion, tires easily. Not changed from baseline.) Treatment included: water, snacks and reassurance/observation for about 40 minutes Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP. Therapeutic measures were taken as a result of tired/fatigue, malaise and shortness of breath. The outcome of the events was unknown.  No follow-up attempts are Possible. No further information is expected.
Chills, all joints ached, low grade fever, headache (pounding) sore throat (3 days).
High blood sugar, (normally 120-160, multiple readings over 200) - blood sugars returned to normal six days later. High PSA as seen on blood work drawn four days after vaccine
Palm sized redness around injection site w/ 3" x 1" darker red spot at site. Fatigue and nausea lasting for 3 days. Still has redness at injection site but improving only low grade temp.
Felt tingle in upper lip 6 days after 2nd shot. Went to sleep feeling like I had a swollen lip. Woke up with a very swollen lip.
PT PRESENTED TO ER ON 2/12/22 PER PT REPORT (DIFFERENT LOCATION THAN WHERE VACCINE WAS ADMINISTERED) PT REPORTS VOMITING, HIVES, SENSATION OF SKIN BURNING, FEVER, LIGHT HEADED WAS GIVEN IV MEDICAITON, ZOFRAN, AND OTHER MEDICATION (DID NOT KNOW NAME), MONITORED FOR 4 HRS THEN RELEASED HOME
On 4/11 i got vaccinted vaccine Johnson & Johnson on Left Arm, on 4/19 I feel my left leg muscle pain from my left sholder to my feetand feel very tied weak body sometime my leg cramp and spasm, until May 18 went to see doctor, did ultra sound and xray on my left leg to to check for blood clut, everything negative, only at my knee have mild osteoarthrosis on 5/26 my left foot swalow  and on  June 9my right foot start pain cannot step on the floor, then start take 5 advil next day morning right foot pain it no more until now i still have a my muscle pain have to take Advil for pain killer
Patient presented to the ED and was subsequently hospitalized on 2/28/2021; within 6 weeks of receiving COVID vaccination.
Joint pain throughout my body, especially in my shoulders, knees, hips, and ankles Muscle weakness throughout my body, especially in the legs, feet, hips, and chest Chest pain  I am planning to go to the doctor soon.
A 4 month old male patient received on 19 March 2007 the second dose of Daptacel (lot # C2552AA), intra-muscular into the left thigh, IPOL (lot# Y1031) (corrected), subcutaneous into the left thigh; Comvax (Merck, lot# MSV0O1-F), into the right thigh; Prevnar (Wyeth, lot#086708) into the right thigh. The patient's left foot began to swell. Treatment was not reported. The patient's outcome was not reported. First dose of Daptacel (lot# C2430AA) given on 17 January 2007, intra-muscular, into left thigh and experienced swelling of left foot and ankle only (approximately twice of normal size), lasted approximately 20 hours and resolved. Denied illness at vaccination time. The patient's medical history included gastroesophageal reflux disease (GERD) and possible heart murmur. The patient was taking Prevacid as concomitant medication. The events reported after first vaccination with Daptacel are captured is case 2007-00213. Follow-up information received on 12 April 2007. The patient received IPOL-Lot number Y1032. There was no treatment provided-no apparent distress. The duration of the symptoms was 20-24 hours, it was reported the patient was fine after that.
No adverse event; patient received expired Moderna Bivalent COVID-19 vaccine on 20DEC2022, after 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired Moderna Bivalent COVID-19 vaccine on 20DEC2022, after 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 29-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7171B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu Shot. Past adverse reactions to the above products included No adverse event with Flu Shot.    On 20-Dec-2022 at 8:19 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Dec-2022 at 8:19 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired Moderna Bivalent COVID-19 vaccine on 20DEC2022, after 12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired Moderna Bivalent COVID-19 vaccine on 20DEC2022, after 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient received expired Moderna Bivalent COVID-19 vaccine on 20DEC2022, after 12 hours post puncture).    No relevant concomitant medications were reported.   The vial was initially stored in the refrigerator on 19-Dec-2022 Date and time 10 am.  Date and time of administration of vaccine was 20-Dec-2022 at 8:19AM. Pre-drawn syringe stored in the refrigerated.   The vial did not undergo any temperature excursions. It was in the refrigerator the entire time if unknown, the vial exposed to room temperature for >24 hours  No treatment information was provided.
Patient states he had no soreness to his left arm. Patient states he got a blood clot. He went to the doctor and his doctor told him that the blood clot he had was not related to the vaccine.
Sudden onset single sided Left TINNITUS. I have NO hearing loss; I have been tested since this onset and no loss is found; moderate to severe single sided LEFT ear TINNITUS
Redness, swelling at injection site that started with a red ring about an inch from the injection opening.  Lethargy/weakness, and vomited about an hour after eating egg and cheese sandwich.
Muscle aches (full body), chills, fever, severe headache.  Lasted for 9 hours.  Treated with ibuprofen and Maxalt. Next day, just fatigue and muscle aches.
pt recv vax & w/in 1hr post vax pt exp quarter sized hives on arms & legs which lasted approx 2hr;pt was given no tx med;
Site: Pain at Injection Site-Severe, Additional Details: Patient consulted with physician after experiencing shoulder pain following 2nd covid shot. Physician diagnosed patient with SIRVA (shoulder injury related to vaccine administration)
Tdap vaccine given IM L deltoid without difficulty.  Approx. 5 minutes after vacc., pt. fainted while standing with mother at check-out desk.  Pt. struck her head on floor - resulting in skull fracture and concussion requiring hospitalization.  8/21/2008 MR received for DOS 6/17-20/2008 with D/C DX: Occipital Skull Fracture. Pt presented from outside facility after pt had ? vasovagal syncope event where pt fell and hit head on a hard surface.  Initially groggy with c/o H/A but became increasingly confused/incoherent. 1 episode of emesis. Pt had brief tonic-clonic activity after arriving in ER. Pt was intubated, loaded with phosphenytoin and transferred to current facility following CT confirmed basilar skull fx.  Pt sedated for PE (+) for bruising to posterior scalp. Extubated on arrival to PICU. Pt had some nausea and sleeping difficulty during stay, but able to d/c 6/20/08 Neurosurgery f/u 7/3/08 doing well, off seizure meds, no h/a, nausea or vomiting. Fx healing well.
Severe soreness/aches, dizziness, nausea, lightheadedness, tightness in chest, fatigue, followed by flu-like symptoms (running nose, sneezing, excessive cough) The flu like symptoms have continued since the shot.
3/17- Patient complained of injection site soreness from the night of the vaccination continued through our last conversation on 3/19/23.  He also stated he had numerous (5-6) loose stools the night of the vaccination.  In addition, he was achy and had electric shock/burning sensation behind his right knee.  The patient had to go to the ER on the evening of 3/16/23 due to extremely elevated blood pressure (235/116 at hospital).  Patient was prescribed amlodipine to only take if his systolic BP was 200+.  Patient didn't have an established PCP at the time, but was going to try to get a video visit with Dr. the week of the 20th to follow up.  I spoke to the patient again on 3/19 and BP was slowly decreasing.  He was also able to get a video visit on 3/20.  The patient stated the nerve symptoms subsided completely since we originally spoke on 3/17.
Overdose; This case was reported by a consumer via media and described the occurrence of overdose in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient had an overdose on Shingrix.  The follow-up would not possible as no contact details were available.
pt mom states 2 days p/having vax c/o neck hurting & had a fever of 102; pt was given APAP & fever did not go down; now refuses to eat or drink & can not move head; seen by DM 23AUG93 in PM;
Fatigue; Fever; Muscle aches on & off; Swollen gland in the throat; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), PYREXIA (Fever), MYALGIA (Muscle aches on & off) and LYMPHADENOPATHY (Swollen gland in the throat) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic fatigue syndrome (She used to have Chronic Fatigue Syndrome 10 years ago and did not have it prior to vaccination.). Concurrent medical conditions included Blood pressure (Taking medicine for High blood pressure).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever), MYALGIA (Muscle aches on & off) and LYMPHADENOPATHY (Swollen gland in the throat). At the time of the report, FATIGUE (Fatigue), PYREXIA (Fever) and MYALGIA (Muscle aches on & off) had not resolved and LYMPHADENOPATHY (Swollen gland in the throat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99f (High) Increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Leg swollen. 3-4 inch diameter area of erythema, macular injection site visible at center positive edema. Seen about 24 hours after vaccine.
Her period started 14 days early; Heavy bleeding (period); This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, on an unspecified date, at the age of 44 years old, as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of the vaccination. The patient did not have COVID-10 prior to BNT162b2. There were no known allergies. The patient stated having received BNT162b2 two weeks prior to the initial reporting. She had been off of her period for about 7 days and she had 14 days before her period started again; her period started 14 days early, on 15Apr2021 at 16:30, which seemed weird to her. The patient felt like this was a side effect from the vaccine. The bleeding was described as heavy. The patient still had menstruation at the time of the reporting. The patient had not tested positive to COVID-19 after the vaccination. The outcome of the event irregular menstrual period was unknown, while the patient had not recovered from the heavy bleeding.   Information on the lot/batch number has been requested.
Information has been received from a consumer concerning his sister who was vaccinated with a dose of MMR II. The reporter stated that when his sister was younger, she had some "delayed reactions and was a little slow." The symptoms developed some time after receiving MMR II. It was unknown if the pt sought medical attention. The reporter also stated that his sister's child developed autism post vaccination with MMR II (WAES0208USA03465). No additional info is expected.
reports feeling dizzy, walked over to EMS for eval and reported feeling anxious and better within 5 minutes, sent home to husband waiting in car
Thi spontaneous report was received from a pharmacist refers to a 41 year old female patient. The patient's medical history included unspecified gastrointestinal (GI) issues. On 29-DEC-2014 the patient was vaccinated with PNEUMOVAX23 lot # K004148, expiry date 10-MAY-2015, 0.5 ml, subcutaneous in the left arm. Concomitant therapies included AMBIEN and probiotics (unspecified). On 29-DEC-2014, later in the evening the patient called the pharmacist and reported itching at the injection site (left arm). The pharmacist recommended that the patient take BENADRYL, for her symptoms. On 30-DEC-2014, the patient called the pharmacist again and reported that her injection site was swollen to the size of a soft ball with pain and redness present. The pharmacist recommended application of ice to the injection site. There were no lab diagnostic studies performed. The patient sought medical attention by calling the pharmacist. There was no product quality complaint involved. The outcome of injection site was swollen to the size of a soft ball with pain and redness present and itching at the injection site was reported as not recovered at the time of the report. The causality of the events was unknown. Additional information has been requested.
I started to experience some itching in my eyes, my nose, and my entire body after my first and second dose of my vaccine. The itching was very intense in my nostrils an eyes. I was given a one time medication of Benadryl. Once I took the Benadryl the itching stopped.
Got the flu like body aches; Got 100 temperature; Had a sore arm but it was mild; Started hurting a little bit more; This is a spontaneous report from a contactable nurse, the patient.  A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248; Expiration Date: Apr2021), intramuscular in the right upper arm on 15Jan2021 at 12:30 (at the age of 69-years-old) as a 0.3 ml single dose for COVID-19 immunization.   Medical history included atrial septal defect, palpitations, and COVID-19 from Aug2020 to an unknown date.  The patient had COVID antibody titers done in Aug2020 and Dec2020 and they were "270." Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), cyanocobalamin (B12-VITAMIIN), estrogens conjugated (PREMARIN), pravastatin (MANUFACTURER UNKNOWN), and escitalopram oxalate (LEXAPRO). On 15Jan2021 after getting the vaccine, the patient had a sore arm but it was mild. Then as the night went on, it started to hurt a little bit more. On 16Jan2021, the patient had flu like body aches, and had a temperature of 100.  The patient did not receive any treatment for the events. The clinical outcome of the sore arm that hurt a little bit more was not recovered; while that of the flu like body aches and a temperature of 100, were unknown. The nurse thought the events were related to the vaccination.
Fever, headache and body aches started 9/12/11 - 9/13/11. Returned to school 9/14/11. Treated with antipyretic.
Pancratitis; Blood sugar spiked very high; Pain in hands and knees; Pain in hands and knees; This is a spontaneous case, initially received from consumer via Med Communication (reference number: SEQ19-06147) on 04-Nov-2019, concerning a 68-year-old, male patient.   The patient's relevant medical history included flu shot in 2018 after which the patient developed pancreatitis. The patient's concomitant medications included Keprom (ketoprofen) and levetiracetam, both for an unknown indication.  On 31-Aug-2019, the patient was administered Afluria Quadrivalent [influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: P100110154 and expiration date: not reported] for influenza prophylaxis.    On 03-Sep-2019, the patient's blood sugar spiked very high and he developed pancreatitis. The patient was hospitalised.  On an unspecified date, the patient experienced pain in hands and knees.   On an unspecified date, the patient was still having trouble with pain in his hands and knees.  The patient was recovering from the events of pancreatitis and increased blood sugar, while the outcome for the events of pain in hands and knees was not recovered, at the time of this report.  The reporter assessed the case as serious bit did not provide causality assessment to Afluria Quadrivalent.  The case was linked with 201905880 (due to same patient).  Company comment: The patient experienced pancreatitis, blood glucose increased, arthralgia and pain in extremity after vaccination with the suspect product Afluria Quadrivalent. Chronology is plausible. Medical history of previous pancreatitis may have contributed to development of the events. Causality was also confounded by therapy with concomitant medications, Keprom (ketoprofen) and levetiracetam. Considering all the above mentioned, causality between suspect product and the events is assessed as possibly related.; Sender's Comments: The patient experienced pancreatitis, blood glucose increased, arthralgia and pain in extremity after vaccination with the suspect product Afluria Quadrivalent. Chronology is plausible. Medical history of previous pancreatitis may have contributed to development of the events. Causality was also confounded by therapy with concomitant medications, Keprom (ketoprofen) and levetiracetam. Considering all the above mentioned, causality between suspect product and the events is assessed as possibly related.
Information has been received from a registered nurse concerning a 12 month old male patient who on 22-JUN-2010, was subcutaneously vaccinated in the left arm with the first dose of VARIVAX (Merck) (Lot# 665900/1604Y), at 9:40 AM. It was reported that on 05-JUL-2010, the patient developed red lesion on the right hand that crusted over and also had few red lesions in diaper area. The patient did not have fever and was acting well. Subsequently, on an unspecified date, the patient recovered. No further information is available.
Approximately two to three mins after immunization she complained of being dizzy. Mother stated she "stiffened" and was unresponsive. Placed supine and immediately responded and began to cry. Remained diaphoretic and pale for several minutes. Observed for 15-20 more minutes. Somewhat lethargic when she left. Several days later mother states she had no other symptoms.
general sluggishness, black bags under eyes, loss of color in face for aprox 2 weeks following vx administration
Crying inconsolably for more than 3 hours. Mother talked to physician on call and gave baby 0.8 ml of concentrated acetaminophen. after 3 hours of crying, gradually stopped crying and fell asleep. He refused feeding at this period.
Information has been received from a physician concerning a 55 year old female with a history of breast cancer who on approximately 29-JUL-2008 was vaccinated subsequently with a dose of MMR II (lot# not reported). On approximately 07-AUG-2008 the patient experienced generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea and vomiting. On 09-AUG-2008 the patient experienced rash on her face, chest and extremities and transient leukopenia. The patient's generalized aches, fatigue, discomfort in her jaw, fever of 103f, nausea, vomiting, rash on her face, chest and extremities and transient leukopenia persisted. In May 2008 the patient's white blood cell count was 5000, on 08-AUG-2008 it was 2000 and on 12-AUG-2008 it was back to 5500. Additional information has been requested.
Information has been received from a physician referring to a 17 year old male patient. The patient's concurrent condition, concomitant medication and medical history were not provided. On an unknown date the patient was vaccinated with the first dose of GARDASIL 9 (strength, dose, frequency, route, lot #, expiration date and indication were not provided). On an unknown date, the patient complained of "not feeling good, was pale and very dizzy, and had to lie down" immediately after receiving the first dose of GARDASIL 9. The outcome of the events was reported as recovered/resolved. The causality assessment was not provided. No product quality compliance involved. This is one of the same report (reported as: different patient, who was also patient's sibling) received from the same reporter.
Pt received flu vax 11/14/06, Frontal HA began 11/16-11/17, had right eye visual field cut CX 11/21/06, MRI 11/22 and Neuro exam DX with MS.  12/15/2006 Hospital MR received revealing a 29 yr old presenting to the ER from the opthomologist office with c/o right-sided blurred vision which began 1 week after her flu vax.  She had noted frontal headaches x 4 days beginning 2-3 days s/p vax. HPI: Pt. went to see eye MD on day of admission due to blurred vision and  partial loss of visual field.  She underwent visual field testing which showed a right inferior temporal field cut in the right eye.  She was refered to the ER where she was admitted for further testing. Impression: Almost certainly multiple sclerosis with first relapse.   02/16/2007 Office notes received from PCP. No new pertinent information./pc 03/02/2007 MR received from neurology consult.  3 F/U visits for MS dxd in hospital from 11/22/2006.  Impression: Relapsing remitting multiple sclerosis-stable.
The patient is a 35 year old female patient of Dr.  She received her 2nd Pfizer vaccine on 8/24/2021.  She notes within 3-4 hour after receiving the vaccine she started feeling weak and short of breath.  She notes with simple exertion she feels short of breath and it takes up to a half hour to regain her breath.   She was seen in the ER on 8/29/2021 with negative d-dimer, labs, CXR, and EKG.  Since being seen in the ER she feels that her symptoms have worsened. She feels OK lying in bed but anytime she exerts herself she feels unwell.   She has felt hot at times, has not taken her temperature.  She feels like she has a headache, her temples feel sore. She had vomiting yesterday.  She briefly had diarrhea yesterday.  She also feels like she has stabbing pain in her upper back and left chest.  Feels like she has left sided chest pressure.  She also feels like her left hand is cold.   Patient was called with CT results the evening of 09/01/2021 and given precautions to seek attention if her symptoms persist or worsen. Offered patient round of steroids if not improving